New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 28, 2022 - Novo Nordisk announced the FDA approval of a 2 mg dose of Ozempic (semaglutide).
Download PDF
Return to publications
